<< Back to Article

References​

1. Macdorman MF, Gregory ECW. Fetal and perinatal mortality, United States, 2013. National vital statistics reports; vol 64 no 8. Hyattsville, MD: National Center for Health Statistics. 2015.

2. Romero R, Chaiworapongsa T, Erez O. An imbalance between angiogenic and anti-angiogenicfactors precedes fetal death in a subset of patients: results of a longitudinal study. J Matern Fetal Neonatal Med. 2010 May 12.10.3109/14767051003681121

3. Gardosi J, Kady SM, McGeown P, Francis A,Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ. 2005; 331:1113–1117.

4. Lee J, Romero R, Dong Z, Xu Y, Qureshi F, Jacques S, Yoo W, Chaiworapongsa T, Mittal P, Hassan SS, Kim CJ. Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies. Histopathology. 2011 Nov; 59(5):928-38.

5. Nielsen HS, Witvliet MD, Steffensen R, et al. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol. 2010 Jul 3.

6. Nielsen HS, Steffensen R, Varming K, Van Halteren AG, Spierings E, Ryder LP, Goulmy E, Christiansen OB. Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. Hum Mol Genet. 2009 May 1; 18 (9):1684-91.

7.Romero R, Whitten A, Korzeniewski SJ, Than NG, Chaemsaithong P, Miranda J, Dong Z, Hassan SS, Chaiworapongsa T. Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection? Am J Reprod Immunol. 2013 Oct; 70(4):285-98.

8. Betkowski AS, Graff R, Chen JJ, Hauptman PJ. Panel-reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant. 2002; 21:644–650.

9. Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, Christiansen OB, Claas F. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol. 2010; 87:67–73.

10. Lee J, Romero R, Xu Y, Kim JS, Topping V, Yoo W, Kusanovic JP, Chaiworapongsa T, Hassan SS, Yoon BH, Kim CJ. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One. 2011; 6:e16806.

11. Espinoza J, Chaiworapongsa T, Romero R, et al. Unexplained fetal death: another anti-angiogenic state. J Matern Fetal Neonatal Med. 2007; 20:495–507.

12. Labarrere CA, McIntyre JA, Faulk WP. Immunohistologic evidence that villitis in human normal term placentas is an immunologic lesion. Am J Obstet Gynecol 1990; 162: 515e22.

13. Brito H, Juliano P, Altemani C, Altemani A. Is the immunohistochemical study of the inflammatory infiltrate helpful in distinguishing villitis of unknown etiology from non-specific infection villitis? Placenta. 2005 Nov; 26(10):839-41.

14. Myerson D, Parkin RK, Benirschke K, Tschetter CN, Hyde SR. The pathogenesis of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in situ hybridization procedure to identify specific maternal and fetal cells. Pediatr Dev Pathol 2006; 9:257e65.

15. Redline RW, Patterson P. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am Pathol. 1993 Aug; 143(2):473-9.

16. Kim J-S, Romero R, Kim MR, Kim YM, Friel L, Espinoza J, et al. Involvement of Hofbauer cells and maternal T cells in villitis of unknown etiology. Histopathology 2008; 52:457e64.

17. Styer AK, Parker HJ, Roberts DJ, et al. Placental villitis of unclear etiology during ovum donor in vitro fertilization pregnancy. Am J Obstet Gynecol 2003; 189:1184-6.

18. Perni SC, Cho JE, Baergen RN. Placental pathology and pregnancy outcomes in donor and non-donor oocyte in vitro fertilization pregnancies. Am J Obstet Gynecol 2003; 189:S122.

19. Yokoyama WM. The mother-child union: the case of missing-self and protection of the fetus. Proc Natl Acad Sci U S A 1997; 94:5998-6000.

20. Derricott H, Jones RL, Heazell AE. Investigating the association of villitis of unknown etiology with stillbirth and fetal growth restriction - a systematic review. Placenta. 2013 Oct; 34(10):856-62.

21. Hulthén Varli I, Petersson K, Kublickas M, Papadogiannakis N. Both acute and chronic placental inflammation are overrepresented in term stillbirths: a case-control study. Infectious Diseases in Obstetrics and Gynecology 2012 Jan; 2012:1e8.

22. Traeder J, Jonigk D, Feist H, Bröcker V, Länger F, Kreipe H, et al. Pathological characteristics of a series of rare chronic histiocytic intervillositis of the placenta. Placenta 2010; 31:1116e9.

23. Mekinian A, Costedoat-Chalumeau N, Masseau A, Botta A, Chudzinski A, Theulin A, Emmanuelli V, Hachulla E, De Carolis S, Revaux A, Nicaise P, Cornelis F, Subtil D, Montestruc F, Bucourt M, Chollet-Martin S, Carbillon L, Fain O; SNFMI and the European Forum of APS. Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. Autoimmunity. 2015 Feb; 48(1):40-5.

24. Doss, B. J., M. F. Greene, J. Hill, et al. 1995. Massive chronic intervillositis associated with recurrent abortions. Hum. Pathol. 26: 1245–1251.

25. Labarrere C, Mullen E. Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: an extreme variant of villitis of unknown etiology. Am J Reprod Immunol Microbiol 1987a; 15:85e91.

26. Boyd TK, Redline WR. Chronic histiocytic intervillositis: a placental lesion associated with recurrent reproductive loss. Hum Pathol 2000; 31:1389e96.

27. Capuani C, Meggetto F, Duga I, Danjoux M, March M, Parant O, Brousset P, Aziza J. Specific infiltration pattern of FOXP3+ regulatory T cells in chronic histiocytic intervillositis of unknown etiology. Placenta. 2013 Feb; 34(2):149-54.

28. Tilburgs T, Scherjon SA, van der Mast BJ, Haasnot GW, Versteeg- VD, Voort- Maarschalk M, et al. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol 2009; 82:148e57.

29. A Parant O, Capdet J, Kessler S, Aziza J, Berrebi A. Chronic intervillositis of unknown etiology (CIUE): relation between placental lesions and perinatal outcome. Eur J Obstet Gynecol Reprod Biol 2009; 143:9e13.

30. Mekinian A, Costedoat-Chalumeau N, Masseau A, Botta A, Chudzinski A, Theulin A, Emmanuelli V, Hachulla E, De Carolis S, Revaux A, Nicaise P, Cornelis F, Subtil D, Montestruc F, Bucourt M, Chollet-Martin S, Carbillon L, Fain O; SNFMI and the European Forum of APS. Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. Autoimmunity. 2015 Feb; 48(1):40-5.

<< Back to Article